A new survey study carried out by The Beckley Foundation and Maastricht University has found that classical psychedelics such as psilocybin and LSD could have painkilling...
Researchers at the University of Alabama, Birmingham, say the study findings demonstrate the critical role of the protein Tiam1 in the pathophysiology of chronic pain-induced mood...
Collaborators of Tryp Therapeutics from the University of Michigan will present two scientific posters at the Society for Neuroscience conference.
Silo Pharma is embarking on a preclinical toxicity study of its novel time-released, dosage-controlled formulation of ketamine – SP-26 – for the treatment of fibromyalgia.
Silo Pharma is preparing a pre-Investigational New Drug (IND) package and meeting request with the United States Food and Drug Administration (FDA) for a novel topical...
